Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 706,000 | 2,113,000 | 1,519,000 | 952,000 | 421,000 |
| Depreciation Amortization | 106,000 | 407,000 | 298,000 | 199,000 | 96,000 |
| Income taxes - deferred | -81,000 | -112,000 | -86,000 | -85,000 | -50,000 |
| Accounts receivable | -31,000 | -628,000 | -423,000 | -184,000 | -96,000 |
| Other Working Capital | 9,000 | -385,000 | -423,000 | -166,000 | -40,000 |
| Other Operating Activity | 51,000 | 743,000 | 431,000 | 200,000 | 131,000 |
| Operating Cash Flow | $760,000 | $2,138,000 | $1,316,000 | $916,000 | $462,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -209,000 | -1,214,000 | -888,000 | -538,000 | -253,000 |
| Purchase Of Investment | -122,000 | -1,036,000 | -1,078,000 | -898,000 | -454,000 |
| Sale Of Investment | 163,000 | 613,000 | 663,000 | 545,000 | 193,000 |
| Purchase Sale Intangibles | 31,000 | 9,000 | 24,000 | 17,000 | -13,000 |
| Other Investing Activity | 31,000 | -44,000 | -29,000 | 17,000 | -13,000 |
| Investing Cash Flow | $-137,000 | $-1,681,000 | $-1,332,000 | $-874,000 | $-527,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 174,000 | 385,000 | 286,000 | 187,000 | 89,000 |
| Common Stock Repurchased | -392,000 | -996,000 | -758,000 | -540,000 | -227,000 |
| Other Financing Activity | 99,000 | 179,000 | 142,000 | 90,000 | 49,000 |
| Financing Cash Flow | $-119,000 | $-432,000 | $-330,000 | $-263,000 | $-89,000 |
| Beginning Cash Position | 1,250,000 | 1,225,000 | 1,225,000 | 1,225,000 | 1,225,000 |
| End Cash Position | 1,754,000 | 1,250,000 | 879,000 | 1,004,000 | 1,071,000 |
| Net Cash Flow | $504,000 | $25,000 | $-346,000 | $-221,000 | $-154,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 760,000 | 2,138,000 | 1,316,000 | 916,000 | 462,000 |
| Capital Expenditure | -209,000 | -1,214,000 | -888,000 | -538,000 | -253,000 |
| Free Cash Flow | 551,000 | 924,000 | 428,000 | 378,000 | 209,000 |